GlassScriptPhysician profile
Thomas T Quach
NPI 1033123146
$966.39
in general payments reported to CMS, 2019-2025
12 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $66.31 · 2021: $78.80 · 2022: $27.78 · 2023: $23.86 · 2024: $144 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.34 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $163.71 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $140.85 | 2025 | Myfembree |
| Phathom Pharmaceuticals, INC. | $124.26 | 2025 | Voquezna |
| Astellas Pharma US INC | $116.41 | 2024-2025 | Veozah |
| Ethicon US, LLC | $72.53 | 2019 | |
| Minerva Surgical, INC | $67.87 | 2020-2021 | |
| Dexcom, INC. | $66.98 | 2024-2025 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $54.48 | 2019-2024 | Paragard T 380a |
| Merz North America, INC. | $53.30 | 2021 | |
| Shield Therapeutics INC | $52.68 | 2023-2024 | Accrufer |
| Avion Pharmaceuticals | $41.01 | 2019 | |
| Pfizer INC. | $12.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Quach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.